274526 Advancing Health-Related Discovery Through Publication

Monday, October 29, 2012 : 12:30 PM - 12:50 PM

Anthony Adams, OD, PhD , School of Optometry, University of California Berkeley, Berkeley, CA
Patient care advances come from discovery, in the broadest sense. Journals and their authors and reviewers play a central role in advancing patient care. Optometry and Vision Science (OVS) is the leading optometry journal world-wide, based on impact factor. It invites publications across broad clinically relevant areas of eye and vision care (including disorders and diseases of the eye, systemic disorders impacting eye and vision [eg diabetes], clinical and basic eye/vision research and related vision/eye public health and epidemiological and quality of life issues). Original Papers, Reviews, Clinical Cases and Technical Reports are published. In this presentation I discuss what authors need to know about the scope of OVS submissions, the submission and review process, the average times for review, the ideal submission, and recent decisions to enhance the content of OVS.

Learning Areas:
Basic medical science applied in public health
Public health or related education

Learning Objectives:
1) Describe the essential elements of an author submission 2) Identify the most common author pitfalls that threaten successful publication. 3) Describe the emerging opportunities for authors in digital communication with their publications

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have been engaged in vision research, with a strong clinical motivation, for 45 years and served on many scientific and professional panels and boards in optometry and ophthalmology. Since 2004 I have been the Editor-in-Chief of Optometry and Vision Science and serve as the chairman of its board of directors. I have been the principal investigator on NIH research projects since 1978 and an NIH PhD Training Grant PI director for almost 30 years.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.